
Rays of Belief IPO
- Issue price
- ₹239
- Listing price
- ₹239
- 0.00%
- Current price
- ₹283.15
- +18.47%
- Subscribed
- 107.71x
- Issue size
- ₹125 Cr
- Listed on
- 8 Sep 2026
IPO timeline
- Opens1 SepTue
- Closes3 SepThu
- Allotment4 SepFri
- Refunds7 SepMon
- Demat credit7 SepMon
- Listing8 SepTue
Issue details
- Price band
- ₹227 – ₹239 per share
- Issue size
- ₹125 Cr
- Fresh issue
- ₹125 Cr · 0.52 Cr shares
- Offer for sale
- None
- Issue type
- Fresh capital only
- Face value
- ₹10 per share
- Lot size
- 62 shares
- Minimum investment
- ₹14,818
- Listing on
- BSE, NSE
- Exchange code
- MOMSBELIEF · 7920
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 62 | ₹14,818 |
| Retail (Max) | 13 | 806 | ₹1,92,634 |
| S-HNI (Min) | 14 | 868 | ₹2,07,452 |
| B-HNI (Min) | 68 | 4,216 | ₹10,07,624 |
Reservation
- QIB
- Not less than 75% of the Issue size
- Retail
- Not more than 10% of the Issue
- NII
- Not more than 15% of the Issue
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on KFin Technologies- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 4 Sep 2026
- Refunds initiated
- 7 Sep 2026
- Shares credited to demat
- 7 Sep 2026
- Listing
- 8 Sep 2026
Grey market premium (GMP)
- Current GMP
- ₹15
- +6.28%
- Estimated listing price
- ₹254
- Issue price ₹239
- Highest
- ₹48
- 31 Aug
- Lowest
- ₹10
- 27 Aug
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 8 Sep 2026 | ₹15 | +6.28% | ₹254 |
| 7 Sep 2026 | ₹15 | +6.28% | ₹254 |
| 6 Sep 2026 | ₹20 | +8.37% | ₹259 |
| 5 Sep 2026 | ₹10 | +4.18% | ₹249 |
| 4 Sep 2026 | ₹12 | +5.02% | ₹251 |
| 3 Sep 2026 | ₹12 | +5.02% | ₹251 |
| 2 Sep 2026 | ₹42 | +17.57% | ₹281 |
| 1 Sep 2026 | ₹38 | +15.90% | ₹277 |
| 31 Aug 2026 | ₹48 | +20.08% | ₹287 |
| 30 Aug 2026 | ₹35 | +14.64% | ₹274 |
| 29 Aug 2026 | ₹26 | +10.88% | ₹265 |
| 28 Aug 2026 | ₹29 | +12.13% | ₹268 |
| 27 Aug 2026 | ₹10 | +4.18% | ₹249 |
| 26 Aug 2026 | ₹18 | +7.53% | ₹257 |
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB9.06x
- NII (HNI)279.11x
- Retail195.87x
| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 18,30,310 | 1,65,76,630 | 9.06x |
| Non-Institutional Investors (NII) | 7,84,500 | 21,89,65,648 | 279.11x |
| bNII — bids above ₹10 Lakh | 5,23,000 | 15,88,98,374 | 303.82x |
| sNII — bids ₹2 Lakh to ₹10 Lakh | 2,61,500 | 6,00,67,274 | 229.7x |
| Retail Individual Investors (RII) | 5,23,000 | 10,24,37,640 | 195.87x |
| Total | 31,37,810 | 33,79,79,918 | 107.71x |
Financials
- P/E Ratio
- 100.84
- EPS (₹)
- 2.37
- RoE
- 21.64%
- RoCE
- 29.74%
- RoNW
- 21.64%
- PAT Margin
- 6.07%
- EBITDA Margin
- 14.59%
- Debt / Equity
- 0.12
- NAV (₹)
- 15.67
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 50.89 | 26.12 | 12.89 |
| Total Income | 82.06 | 36.54 | 30.76 |
| Profit After Tax | 4.96 | 5.88 | 0.85 |
| EBITDA | 11.91 | 3.02 | 1.49 |
| NET Worth | 30.81 | 15.02 | 5.78 |
| Reserves and Surplus | 15.22 | 14.70 | 5.47 |
| Total Borrowing | 3.61 | 4.36 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Rays of Belief This IPO | ₹125 Cr | 100.84 | 21.64% | 6.07% | 107.71x | 0.00% |
| Indogulf Cropsciences Mainboard · listed 3 Jul 2025 | ₹200 Cr | 24.27 | 12.19% | 5.11% | 27.05x | 0.00% |
| Shringar House of Mangalsutra Mainboard · listed 17 Sep 2025 | ₹400.92 Cr | 26.04 | 36.20% | 4.27% | 60.31x | +14.24% |
| Concord Enviro Systems Mainboard · listed 27 Dec 2024 | ₹500.33 Cr | 1171.52 | 12.92% | 8.34% | 10.72x | +17.83% |
| Capital Small Finance Bank Mainboard · listed 14 Feb 2024 | ₹523.07 Cr | 19.35 | 15.33% | — | 4.17x | -8.07% |
| Mufti Mainboard · listed 27 Dec 2023 | ₹549.78 Cr | 23.23 | 29.98% | 15.56% | 51.85x | +0.84% |
| Ivalue Infosolutions Mainboard · listed 25 Sep 2025 | ₹560.29 Cr | 18.77 | 22.02% | 8.87% | 1.82x | -4.70% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Rays of Belief plans to use the money raised, as stated in the offer document.
- Company Learning Centres and Company Learning Centres in partnership with Licensed Professionals₹26.88 Cr
- School Collaboration Centres₹5.54 Cr
- Centre for Excellence and Research₹2.45 Cr
- Upskilling Academy₹2.05 Cr
- Technology (hardware) costs₹4.44 Cr
- Expenditure for lease payments for existing centres in India₹14.45 Cr
- Investment in Subsidiary, Moms Belief US Inc., for making lease / license payments for existing centres in the USA₹10.13 Cr
- Expenditure for brand awareness and inclusive outreach programs₹10.21 Cr
- Funding inorganic growth through unidentified acquisition and General corporate purposes
About Rays of Belief
Rays of Belief Ltd was started in 2017. It is a for-profit social enterprise that makes personalised intervention plans for children with neurodevelopmental disorders. These include Autism Spectrum Disorder, ADHD, Down Syndrome, Cerebral Palsy, intellectual disability, learning disabilities and global developmental delays. The company opened its first centre in Gurgaon in 2018 and works under the brand name Mom's Belief. It has grown from 71 centres in FY2023 to 136 centres as on 31 March 2026, spread across 57 cities and 20 states and union territories. Of these, 42 are in Tier 1 cities, 77 in Tier 2 and 17 in Tier 3, so a large part of the network is in smaller cities where such care is harder to find. It mainly works with children between 18 months and 12 years, and runs special programmes on vocational and life skills for children up to 15 years. Its services include early intervention, parental guidance, occupational therapy, language therapy and family support. Its centres carry more than 150 teaching tools and its home based learning kits give access to more than 2,000 teaching tools, with regular follow up and progress tracking. As on 31 March 2026 it had a team of over 340 full time clinical professionals. In June 2025 it bought Mom's Belief US, Inc. as a wholly owned subsidiary along with Allergy and Immunology Virginia, LLC, adding three centres in Virginia at Salem, Lynchburg and Roanoke.
Strengths
- The centre network has grown fast, from 71 centres in FY2023 to 136 centres as on 31 March 2026, across 57 cities and 20 states and union territories.
- Total income grew 125% in FY2026, from Rs 36.54 crore to Rs 82.06 crore.
- EBITDA improved sharply, from Rs 1.49 crore in FY2024 to Rs 3.02 crore in FY2025 and Rs 11.91 crore in FY2026.
- The company carries almost no debt. Total borrowing was only Rs 3.61 crore against a net worth of Rs 30.81 crore as on 31 March 2026.
- A large part of the network is in smaller cities, with 77 Tier 2 and 17 Tier 3 centres, where there are few options for this kind of care.
- It has a qualified team of more than 340 full time clinical professionals and a structured set of tools, with over 150 at the centres and more than 2,000 through home kits.
- It has entered the USA through the June 2025 purchase of Mom's Belief US, Inc., adding three centres in Virginia.
- Awareness and diagnosis of neurodevelopmental disorders is rising in India, and organised providers in this field are still few.
Risks
- Profit fell even as sales more than doubled. Profit after tax came down 16% in FY2026, from Rs 5.88 crore to Rs 4.96 crore, while income rose 125%. The cost of opening centres is running ahead of the income they bring.
- The FY2026 figures are on a consolidated basis while the earlier years are standalone, as noted on the offer document, so the growth is not a like for like comparison.
- Return on capital employed is low at 7.49%, which shows the money put into building the centre network is not yet earning much.
- The price band, issue size and lot size have not been announced yet, so the valuation cannot be judged at this stage.
- A large part of the money is for rent rather than for assets. About Rs 14.45 crore is for lease payments on existing centres in India and Rs 10.13 crore for lease and licence payments in the USA, which are running costs and do not create anything that can be sold later.
- A further part is kept for an unidentified acquisition and general corporate purposes, so investors do not know where that money will go.
- The business depends on trained clinical staff. Finding and keeping therapists across 136 centres in 57 cities is difficult, and quality can vary between centres.
- Families pay for this care mostly out of their own pocket, as insurance cover for developmental therapy is limited in India, so demand is sensitive to household budgets.
- The US business is new, bought only in June 2025, and is a very different market in terms of regulation, insurance and cost.
Promoters and shareholding
Nitin Bindlish and Carving Futures Pte.Ltd
- Promoter holding, pre-issue
- 92.93%
- Promoter holding, post-issue
- —
Anchor investors
| Investor | Shares allotted | Amount | % of anchor book |
|---|---|---|---|
| VINEY GROWTH FUND | 6,27,626 | ₹15 Cr | 30% |
| LRSD SECURITIES PVT.LTD. | 6,27,626 | ₹15 Cr | 30% |
| NOVA GLOBAL OPPORTUNITIES FUND PCC-TOUCHSTONE | 4,18,438 | ₹10 Cr | 20% |
| 31 Degrees North Fund I | 2,09,250 | ₹5 Cr | 10% |
| VISIONARY VALUE FUND | 2,09,250 | ₹5 Cr | 10% |
Registrar, lead managers and documents
Company contact
J-1919, Basement, Chittranjan Park, New Delhi, Delhi, New Delhi, 110019
+91 124 407549
cs@momsbelief.comRays of Belief IPO: common questions
1.When does the Rays of Belief IPO open and close?
The Rays of Belief IPO opens on 1 Sep 2026 and closes on 3 Sep 2026.
2.What is the price band of the Rays of Belief IPO?
The price band is ₹227 – ₹239 per share, with a lot size of 62 shares and a minimum investment of ₹14,818.
3.What is the size of the Rays of Belief IPO?
The issue size is ₹125 Cr (Fresh capital only).
4.What is the GMP of the Rays of Belief IPO?
The last reported grey market premium is ₹15 per share as of 08 Sep 2026, 08:24 AM IST. GMP is unofficial and changes frequently.
5.When is the Rays of Belief IPO allotment?
The basis of allotment is expected on 4 Sep 2026. Allotment status can be checked with the registrar, KFin Technologies Limited.
6.When will the Rays of Belief IPO list?
The shares listed on 8 Sep 2026 on BSE, NSE.
7.What will the money raised in the Rays of Belief IPO be used for?
As stated in the offer document, the proceeds are for: Company Learning Centres and Company Learning Centres in partnership with Licensed Professionals; School Collaboration Centres; Centre for Excellence and Research; Upskilling Academy; Technology (hardware) costs.
8.How can my company launch an IPO like Rays of Belief?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393